Cataract surgery replaces your eye’s clouded natural lens with an artificial one — and which lens you choose shapes how you see for the rest of your life. Here’s how to think it through…

Eye pain, cloudy vision, redness, light sensitivity, or a visible growth on the eye may be signs of a corneal condition that needs expert evaluation.

Dr. Robert Feinfield has been working with botulinum toxin since 1986 — sixteen years before it was approved for cosmetic use. Nearly 40 years later, he brings that same surgical precision to…

Why Your Dry Eye Treatment Isn’t Working — And What to Do About It in Los Angeles

Most dry eye patients in Los Angeles have already tried something before they find the right doctor. Artificial tears. Restasis for six months with no noticeable improvement. A warm compress. A sample of something from an optometrist. They’re still burning, still blurring out by mid-afternoon, and still waiting for someone to explain what’s actually going on.

The most common reason dry eye treatment fails is that no one has identified which type of dry eye is driving the problem before reaching for a prescription. That’s the starting point at the Dry Eye Center at Berg-Feinfield Vision Correction — the first diagnosis-first dry eye practice in the Los Angeles area, with dedicated dry eye care at their Burbank and Sherman Oaks locations.

What Causes Dry Eye Disease?

Dry eye disease is caused by one of two mechanisms — or, in most cases, a combination of both. Understanding which mechanism is dominant is the single most important factor in choosing the right treatment.

Aqueous-deficient dry eye occurs when the lacrimal glands don’t produce enough tears. It’s more common with age, autoimmune conditions like Sjögren’s syndrome, certain medications (antihistamines, antidepressants, blood pressure medications), and sometimes after LASIK surgery.

Evaporative dry eye is caused by meibomian gland dysfunction (MGD), where the oil-producing glands in the eyelids become clogged or underperform. Without a healthy oil layer, tears evaporate too quickly — even when production is normal. MGD is the most common cause of dry eye disease today and the form most frequently missed in a routine eye exam.

Most patients have elements of both. An anti-inflammatory drop designed to increase tear production won’t help if the real problem is that tears are evaporating in three seconds because the meibomian glands are blocked. A gland-clearing treatment won’t resolve symptoms driven primarily by inflammation. Artificial tears — regardless of brand or frequency — only manage symptoms without addressing the underlying cause.

What Are the Symptoms of Dry Eye Disease?

The most common symptoms of dry eye disease include burning, stinging, or a scratchy sensation in the eyes; a persistent gritty feeling like something is in the eye; fluctuating or blurred vision that worsens in the evening or after extended screen time; excessive watering (a paradoxical reflex response to underlying dryness); stringy mucus, redness, or sensitivity to light and wind; difficulty wearing contact lenses comfortably; and eye fatigue by mid-afternoon.

If three or more of these symptoms are present, dry eye disease is likely contributing to the problem — and a comprehensive evaluation, not another bottle of artificial tears, is the appropriate next step.

How Is Dry Eye Diagnosed in Los Angeles?

A proper dry eye diagnosis requires more than a brief slit lamp exam and a prescription. At Berg-Feinfield’s Dry Eye Center in Los Angeles, every evaluation includes six diagnostic tests designed to identify which mechanism is driving each patient’s case.

Tear osmolarity testing measures the salt concentration in the tears — elevated osmolarity is one of the most reliable objective markers of dry eye disease. Tear breakup time (TBUT) measures how quickly the tear film destabilizes between blinks, pointing directly to evaporative dry eye when the result is short. Meibomian gland imaging and expression assesses the structure and function of the oil-producing glands, identifying MGD. Corneal and conjunctival staining with fluorescein and lissamine green reveals actual surface damage on the eye that may not be visible without dye. Schirmer testing measures tear production volume directly when aqueous deficiency is suspected. And the Ocular Surface Disease Index (OSDI) questionnaire provides a validated severity score that serves as a baseline for tracking treatment response over time.

This combination tells the full story — which mechanism is dominant, how advanced the disease is, and which treatments are appropriate — before anything is prescribed.

What Are the Best Dry Eye Treatments Available in Los Angeles?

The Dry Eye Center at Berg-Feinfield offers 11 targeted treatments for dry eye disease, organized in tiers and selected based on what the diagnostic workup reveals. Most patients in Los Angeles who visit the center end up on a tailored combination of two or three treatments matched to their specific mechanism.

For inflammation-driven dry eye, prescription options include Restasis (cyclosporine 0.05%), Vevye (a newer water-free cyclosporine 0.1% formulation that is better tolerated and shows efficacy in as few as four weeks), and Tryptyr — a newer mechanism of action for patients who haven’t responded to traditional anti-inflammatory drops.

For evaporative dry eye caused by meibomian gland dysfunction, Miebo is a first-in-class, preservative-free, water-free drop that directly reduces tear evaporation by stabilizing the lipid layer — it’s not an anti-inflammatory and addresses a completely different part of the problem. iLux thermal gland expression is an in-office procedure that heats and clears blocked meibomian glands in a single visit, treating the root cause of evaporative dry eye rather than just managing symptoms.

For aqueous-deficient dry eye, punctal plugs — tiny devices inserted into the tear drainage ducts — help retain more natural tears on the ocular surface. Berg-Feinfield also offers Lacrifill, a hyaluronic acid canalicular gel that conforms to each patient’s anatomy, stays effective for approximately six months, and dissolves naturally — without the extrusion, sizing issues, or foreign body sensation common with traditional plugs.

Preservative-free artificial tears serve as foundation and bridge therapy for mild cases and between treatments.

What Is Meibomian Gland Dysfunction (MGD)?

Meibomian gland dysfunction is a chronic condition in which the meibomian glands — small oil-producing glands located along the upper and lower eyelid margins — become blocked, atrophied, or produce poor-quality oil. Because the oil (meibum) layer is responsible for preventing tear evaporation, MGD leads to an unstable tear film that breaks apart too quickly between blinks. This is the primary driver of evaporative dry eye, which accounts for the majority of dry eye disease cases.

MGD is frequently underdiagnosed because it doesn’t always present with obvious redness or discomfort in early stages, and standard eye exams don’t always include gland imaging or expression testing. By the time symptoms become significant, structural gland damage may already be present — which is why early diagnosis and treatment matter.

In Los Angeles, Berg-Feinfield’s Dry Eye Center evaluates meibomian gland function as part of every dry eye workup, using both imaging and manual expression to assess gland health before recommending treatment.

What Is the Difference Between Restasis, Vevye, Miebo, and Tryptyr?

These four prescription dry eye medications each work through different mechanisms and target different aspects of dry eye disease. They are not interchangeable, and the right choice depends on which type of dry eye a patient has.

Restasis (cyclosporine 0.05%) is an anti-inflammatory immunomodulator that increases natural tear production over time. It has been available the longest but can take three to six months to show full effect and causes stinging on instillation for many patients.

Vevye (cyclosporine 0.1%) is a newer, water-free formulation that delivers a higher concentration of cyclosporine in a perfluorobutylpentane vehicle. Because the formulation contains no water, it has no pH and no osmolarity — making it significantly more comfortable on instillation. Clinical data shows efficacy in as little as four weeks.

Miebo (perfluorohexyloctane) is not an anti-inflammatory. It is the first FDA-approved drop specifically designed to reduce tear film evaporation in patients with meibomian gland dysfunction. It works by supplementing the lipid layer of the tear film, addressing the evaporative mechanism directly.

Tryptyr (acoltremon ophthalmic solution 0.003%) represents a newer mechanism of action for dry eye disease, particularly for patients who have not responded adequately to cyclosporine-based therapies.

A diagnosis-first practice like Berg-Feinfield’s Dry Eye Center in Los Angeles determines which of these medications — alone or in combination — is appropriate based on objective testing, not trial and error.

What Is Lacrifill and How Does It Compare to Punctal Plugs?

Lacrifill is a cross-linked hyaluronic acid canalicular gel that provides punctal occlusion — the same function as traditional punctal plugs — through a different delivery method. Instead of inserting a solid silicone or collagen plug into the punctum, the gel is injected into the canalicular system where it conforms to the individual anatomy of each patient’s tear drainage ducts.

Lacrifill stays effective for approximately six months and dissolves naturally. It does not cause the foreign body sensation, self-extrusion, or sizing complications associated with traditional plugs. Because hyaluronic acid is a natural component of the tear film, the gel is well tolerated and provides continuous lubrication as it gradually breaks down.

At Berg-Feinfield’s Los Angeles Dry Eye Center, Lacrifill is offered as an alternative to traditional punctal plugs for patients with aqueous-deficient dry eye who need tear conservation but have had issues with conventional plug approaches.

Who Should See a Dry Eye Specialist in Los Angeles?

A dry eye evaluation at a dedicated center like Berg-Feinfield is appropriate for anyone in the Los Angeles area who has tried over-the-counter drops or a single prescription without meaningful improvement; experiences burning, stinging, grittiness, or blurred vision that worsens through the day or with screen use; has been told they have dry eye but was never told which type; has watery eyes that seem contradictory to a dry eye diagnosis; wears contact lenses that have become increasingly uncomfortable; or is preparing for LASIK or cataract surgery and needs to optimize the ocular surface before the procedure.

Where Is the Berg-Feinfield Dry Eye Center Located?

The Dry Eye Center at Berg-Feinfield Vision Correction offers comprehensive dry eye evaluations and treatment at two dedicated locations in Los Angeles: Burbank and Sherman Oaks. The practice serves patients throughout Los Angeles, Beverly Hills, Studio City, Encino, Toluca Lake, Pasadena, Arcadia, and Valencia. Berg-Feinfield has been in practice for over 30 years.

To schedule a dry eye evaluation, visit bergfeinfield.com/los-angeles-dry-eye-center or call 866-2-SEE FAR.

LASIK is not the only vision correction option. Depending on your age, prescription, corneal anatomy, and long-term visual goals, the best refractive procedure may be LASIK, PRK, EVO ICL, or…

Berg-Feinfield is the first practice in Los Angeles to offer Epioxa — the first FDA-approved epi-on corneal cross-linking therapy for keratoconus.

Considering Botox for the first time raises practical questions. You want smoother skin, but you also need to know what you’re signing up for. Will one treatment be enough, or does maintaining results require regular visits? These questions matter when you’re making decisions about your appearance and budget.

Keep reading to learn how long Botox lasts, what factors influence its duration, and when you’ll need follow-up treatments to maintain your refreshed appearance.

Read More about Are the Effects of Botox Permanent?

Glaucoma is a serious eye condition that can lead to permanent vision loss if left untreated. Often referred to as the “silent thief of sight,” glaucoma can develop without noticeable symptoms, making it difficult for you to know if you have the condition until significant damage has already occurred. 

This is why understanding the nature of glaucoma, its potential warning signs and the importance of regular eye exams is crucial for maintaining healthy vision. Keep reading to learn more about glaucoma and its possible symptoms!

What is Glaucoma?

Glaucoma is a group of eye conditions that can cause progressive damage to the optic nerve, which is the vital connection between the eye and the brain. This damage is often caused by increased pressure within the eye, known as intraocular pressure or IOP. 

Increased eye pressure happens when there is too much fluid inside the eye. This can happen due to an overproduction of fluid or a blockage in the outflow of fluid. 

Since your eye is constantly creating fluid, this fluid must cycle out of the eye to maintain healthy eye pressure levels. If left untreated, glaucoma can lead to vision loss and even blindness. 

What Are the Warning Signs of Glaucoma?

One of the most challenging aspects of glaucoma is that it often develops without noticeable symptoms, especially in its early stages. This is why glaucoma is often referred to as the “silent thief of sight.” 

However, as the condition progresses, some warning signs may appear:

• Gradual loss of peripheral (side) vision
• Seeing halos around lights
• Eye pain or discomfort
• Redness in the eye
• Blurred vision
• Tunnel vision (in advanced stages)

It is important to note that these symptoms may not occur in all cases, and just because you don’t have these symptoms, it does not necessarily mean you do not have glaucoma. Regular eye exams are the best way to detect glaucoma early and prevent vision loss.

How Can You Tell if You Have Glaucoma?

The best way to determine if you have glaucoma is through a comprehensive eye exam with your eye doctor at Berg Feinfield Vision Correction. During the exam, your eye doctor will:

• Measure your intraocular pressure (tonometry)
• Inspect the drainage angle of your eye (gonioscopy)
• Evaluate your optic nerve for damage (ophthalmoscopy)
• Test your peripheral vision (visual field test)
• Measure the thickness of your cornea (pachymetry)

These tests are painless and non-invasive, and they provide your eye doctor with the information needed to determine your risk for glaucoma and plan the best course of treatment, if necessary.

Could I Be at Risk For Glaucoma?

Several factors can increase your risk of developing glaucoma, such as:

Age

The risk of glaucoma increases with age, particularly after sixty.

Family History

Having a family member with glaucoma increases your risk.

Race

African Americans, Hispanics, and Asians are at a higher risk for certain types of glaucoma.

Certain Medical Conditions

Diabetes, high blood pressure, and heart disease can increase your risk.

Eye Injuries 

Trauma to the eye can lead to glaucoma.

Prolonged Corticosteroid Use 

Long-term use of corticosteroids, particularly eye drops, can increase your risk.

If you have any of these risk factors, it is especially important to have regular eye exams to monitor your eye health and detect any signs of glaucoma early.

At Berg Feinfield Vision Correction, we understand the importance of early detection and treatment of glaucoma. Our experienced team of eye care professionals is dedicated to providing comprehensive eye exams and state-of-the-art treatment options to help preserve your vision.

Do you have questions about glaucoma or want to determine if you may be at risk? Schedule an appointment at Berg Feinfield Vision Correction in Burbank, CA, today!